Hereditary Testing Market Size And Forecast 2026–2030: Trends Driving Industry Expansion

Hereditary Testing Market Report

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

Hereditary Testing Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?

The hereditary testing market size has shown robust growth over recent years. It is anticipated to expand from $6.62 billion in 2025 to $7.23 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.2%. The expansion observed in the past can be credited to improvements in genetic sequencing technologies, heightened awareness of inherited disorders, the broadening of clinical genetics programs, a decrease in the cost of genetic testing, and the proliferation of diagnostic laboratory networks.

The hereditary testing market is anticipated to experience substantial growth in the coming years. Its valuation is projected to reach $10.17 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.9%. This expansion during the forecast period is primarily driven by factors such as the increasing integration of genomics into routine medical care, a rising demand for precision medicine applications, the broadening of population-scale genetic screening, the growing deployment of digital platforms for genetic data, and an increasing focus on preventive healthcare genomics. Key trends identified for the forecast period include the greater adoption of next-generation sequencing tests, an escalating need for predictive and carrier genetic testing, the expanded use of AI-based variant interpretation, the enlargement of prenatal and newborn screening programs, and an enhanced emphasis on personalized genetic counseling.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=45064308&type=smp&name=Hereditary%20Testing%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Nov_PR

Hereditary Testing Market Industry Drivers: What’s Behind The Revenue Growth?

The rising occurrence of genetic conditions is set to drive the expansion of the hereditary testing market moving forward. Genetic disorders are defined as medical ailments resulting from irregularities or alterations in an individual’s deoxyribonucleic acid, which can be passed down from one or both parents or emerge spontaneously. The escalation in genetic disorders is partially linked to increased parental age, which heightens the probability of genetic mutations being transferred to offspring. Hereditary testing provides support to patients with genetic disorders by enabling early diagnosis, guiding customized treatment plans, and assisting in family planning decisions through the identification of inherited mutations. For instance, in October 2024, data from the Cystic Fibrosis Trust, a UK-based charitable organization, indicated that the count of patients registered with cystic fibrosis climbed to 11,318 in 2023, an increase from 11,148 in 2022. Thus, the growing prevalence of genetic disorders is propelling the growth of the hereditary testing market.

Hereditary Testing Market Segment Analysis: What Are The Core Market Categories?

The hereditary testing market covered in this report is segmented –

1) By Test Type: Predictive Testing, Carrier Testing, Prenatal Testing, Newborn Screening, Diagnostic Testing, Other Test Types

2) By Sample Type: Blood Samples, Saliva Samples, Tissue Samples, Buccal Swabs, Amniotic Fluid And Cord Blood Samples

3) By Technology Used: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Sanger Sequencing, Microarray Technology, Whole Genome Sequencing (WGS)

4) By Application: Oncology, Cardiovascular Diseases, Neurological Disorders, Metabolic Disorders, Other Applications

5) By End User: Hospitals, Diagnostic Laboratories, Research Institutes, Pharmaceutical Companies, Patients And Consumers

Subsegments:

1) By Predictive Testing: Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Gene Mutation Testing, Lynch Syndrome Testing, Familial Hypercholesterolemia Testing, Huntington’s Disease Testing, Cardiomyopathy Genetic Testing

2) By Carrier Testing: Cystic Fibrosis Carrier Screening, Tay-Sachs Carrier Screening, Spinal Muscular Atrophy (SMA) Carrier Screening, Thalassemia Carrier Screening, Sickle Cell Carrier Testing

3) By Prenatal Testing: Non-Invasive Prenatal Testing (NIPT), Chorionic Villus Sampling (CVS), Amniocentesis, Expanded Carrier Screening (Prenatal Context), Cell-Free Fetal Deoxyribonucleic Acid Testing

4) By Newborn Screening: Phenylketonuria (PKU) Screening, Congenital Hypothyroidism Screening, Cystic Fibrosis Screening, Sickle Cell Disease Screening, Hearing Loss and Metabolic Disorder Panels

5) By Diagnostic Testing: Rare Disease Genetic Testing, Inherited Cancer Diagnostic Testing, Cardiogenetic Diagnostic Panels, Neurogenetic Disorder Testing, Monogenic Disease Panels

6) By Other Test Types: Pharmacogenomics Testing, Preimplantation Genetic Diagnosis (PGD), Whole Exome Sequencing (WES), Whole Genome Sequencing (WGS), Mitochondrial Deoxyribonucleic Acid Testing

Hereditary Testing Market Growth Trends Reshaping The Competitive Landscape

Companies prominent in the hereditary testing market are concentrating on advancements in genetic test kit technology. This focus aims to improve testing precision, decrease processing times, and enable the identification of a wider array of genetic mutations. Genetic test kits are diagnostic instruments crafted for the analysis of an individual’s deoxyribonucleic acid (DNA), seeking to pinpoint genetic mutations or variations associated with inherited conditions or disease susceptibility. As an illustration, in July 2023, Devyser Diagnostics AB, a Sweden-based biotechnology firm dedicated to creating, producing, and selling DNA diagnostic kits for hereditary disease testing, introduced two novel targeted next-generation sequencing kits: Devyser LynchFAP and Devyser BRCA PALB2. Devyser LynchFAP provides an unparalleled comprehensive analysis of PMS2 (addressing issues presented by its pseudogene PMS2CL) in conjunction with nine other vital genes connected to hereditary colorectal cancer syndromes. Devyser BRCA PALB2 presents a straightforward single-tube method for screening BRCA1, BRCA2, and PALB2 mutations in both blood and tumor specimens. It is engineered to facilitate smoother laboratory procedures and deliver effective, simple-to-use sequencing with specialized software, thereby aiding in the reliable detection of hereditary cancer risks.

Hereditary Testing Market Top Companies Driving Competitive Growth

Major companies operating in the hereditary testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., CooperSurgical Inc., QIAGEN N.V, Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc, Invitae Corporation, GeneDx LLC, Twist Bioscience Corporation, Color Health Inc., MedGenome Inc, SOPHiA GENETICS SA, Gene By Gene Ltd., Dante Labs Inc., 23mofang Co. Ltd.

View The Full Hereditary Testing Market Report:

https://thebusinessresearchcompany.com/report/hereditary-testing-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Nov_PR

Hereditary Testing Market Top Region By Revenue And Market Share

North America was the largest region in the hereditary testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hereditary testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model